Cargando…

Nigrosome-1 on Susceptibility Weighted Imaging to Differentiate Parkinson’s Disease From Atypical Parkinsonism: An In Vivo and Ex Vivo Pilot Study

BACKGROUND: Previous case-control studies have suggested that the absence of a swallow-tail appearance in the substantia nigra on high-resolution SWI, representing nigrosome-1, has high accuracy to identify Parkinson’s disease (PD). The first goal of our study was to evaluate nigrosome-1 ex vivo usi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Meijer, Frederick J.A., Steens, Stefan C., van Rumund, Anouke, van Cappellen van Walsum, Anne-Marie, Küsters, Benno, Esselink, Rianne A.J., Verbeek, Marcel M., Bloem, Bastiaan R., Goraj, Bożena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International Scientific Literature, Inc. 2016
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4975367/ https://www.ncbi.nlm.nih.gov/pubmed/27559425 http://dx.doi.org/10.12659/PJR.897090

Ejemplares similares

Conventional 3T brain MRI and diffusion tensor imaging in the diagnostic workup of early stage parkinsonism
por: Meijer, Frederick J. A., et al.
Publicado: (2015)

Parkinson’s Disease Diagnostic Observations (PADDO): study rationale and design of a prospective cohort study for early differentiation of parkinsonism
por: van Rumund, Anouke, et al.
Publicado: (2018)

Inflammation biomarker discovery in Parkinson’s disease and atypical parkinsonisms
por: Santaella, Anna, et al.
Publicado: (2020)

Factors associated with mortality in early stages of parkinsonism
por: van Rumund, Anouke, et al.
Publicado: (2022)

Clinical Application of Brain MRI in the Diagnostic Work-up of Parkinsonism
por: Meijer, Frederick J.A., et al.
Publicado: (2017)

α‐Synuclein real‐time quaking‐induced conversion in the cerebrospinal fluid of uncertain cases of parkinsonism
por: van Rumund, Anouke, et al.
Publicado: (2019)

Cerebrospinal fluid monocyte chemoattractant protein 1 correlates with progression of Parkinson’s disease
por: Santaella, Anna, et al.
Publicado: (2020)

Cerebrospinal Fluid Galectin-1 Levels Discriminate Patients with Parkinsonism from Controls
por: Marques, Tainá M., et al.
Publicado: (2018)

MicroRNAs in Cerebrospinal Fluid as Potential Biomarkers for Parkinson’s Disease and Multiple System Atrophy
por: Marques, Tainá M., et al.
Publicado: (2016)

Identification of cerebrospinal fluid biomarkers for parkinsonism using a proteomics approach
por: Marques, Tainá M., et al.
Publicado: (2021)

Contribution of routine brain MRI to the differential diagnosis of parkinsonism: a 3-year prospective follow-up study
por: Meijer, Frederick J. A., et al.
Publicado: (2011)

Peripheral decarboxylase inhibitors paradoxically induce aromatic L-amino acid decarboxylase
por: van Rumund, Anouke, et al.
Publicado: (2021)

Nigrosome and Neuromelanin Imaging as Tools to Differentiate Parkinson's Disease and Parkinsonism
por: Biswas, Deblina, et al.
Publicado: (2022)

Trait Impulsivity Is Associated with the Risk of Falls in Parkinson’s Disease
por: Smulders, Katrijn, et al.
Publicado: (2014)

Modified Iron Deposition in Nigrosomes by Pharmacotherapy for the Management of Parkinson’s Disease
por: Wang, Mengdi, et al.
Publicado: (2022)

Asymmetric Parkinsonism With Progressive Nigrosomal Change Secondary to Kernohan’s Notch Phenomenon
por: Kim, Han-Kyeol, et al.
Publicado: (2022)

Gender Distribution in Deep Brain Stimulation for Parkinson’s Disease: The Effect of Awake versus Asleep Surgery
por: Vinke, R. Saman, et al.
Publicado: (2022)

Imaging white matter microstructure with gradient‐echo phase imaging: Is ex vivo imaging with formalin‐fixed tissue a good approximation of the in vivo brain?
por: Chan, Kwok‐Shing, et al.
Publicado: (2022)

T2-Imaging Changes in the Nigrosome-1 Relate to Clinical Measures of Parkinson’s Disease
por: Fu, Katherine A., et al.
Publicado: (2016)

Cortical thinning pattern according to differential nigrosome involvement in patients with Parkinson’s disease
por: Shin, Na-Young, et al.
Publicado: (2020)

The Role of Microelectrode Recording in Deep Brain Stimulation Surgery for Parkinson’s Disease: A Systematic Review and Meta-Analysis
por: Vinke, R. Saman, et al.
Publicado: (2022)

Assessment of dual tasking has no clinical value for fall prediction in Parkinson’s disease
por: Smulders, Katrijn, et al.
Publicado: (2012)

Comparison of 6-[(18)F]FDOPA PET with Nigrosome 1 detection in patients with parkinsonism
por: Michler, Enrico, et al.
Publicado: (2021)

Mechanisms of peripheral levodopa resistance in Parkinson’s disease
por: Beckers, Milan, et al.
Publicado: (2022)

Enhanced motivation of cognitive control in Parkinson's disease
por: Timmer, Monique H.M., et al.
Publicado: (2018)

Translating Evidence to Advanced Parkinson's Disease Patients: A Systematic Review and Meta‐Analysis
por: Nijhuis, Frouke A.P., et al.
Publicado: (2021)

A LRSAM1 mutation links Charcot–Marie–Tooth type 2 to Parkinson's disease
por: Aerts, Marjolein B., et al.
Publicado: (2015)

Visualizing the trigeminovagal complex in the human medulla by combining ex-vivo ultra-high resolution structural MRI and polarized light imaging microscopy
por: Henssen, D. J. H. A., et al.
Publicado: (2019)

People with Parkinson’s as Partners for the Journal of Parkinson’s Disease
por: McFarthing, Kevin, et al.
Publicado: (2023)

Prospective assessment of subjective sleep benefit in Parkinson’s disease
por: van Gilst, Merel M, et al.
Publicado: (2015)

Parkinson’s Disease: We Care!
por: Bloem, Bastiaan R., et al.
Publicado: (2020)

Parkinson's disease related signal change in the nigrosomes 1–5 and the substantia nigra using T2* weighted 7T MRI
por: Schwarz, Stefan Theodor, et al.
Publicado: (2018)

Imaging the Nigrosome 1 in the substantia nigra using susceptibility weighted imaging and quantitative susceptibility mapping: An application to Parkinson's disease
por: Cheng, Zenghui, et al.
Publicado: (2019)

Early‐stage Parkinson's disease: Abnormal nigrosome 1 and 2 revealed by a voxelwise analysis of neuromelanin‐sensitive MRI
por: Sung, Young Hee, et al.
Publicado: (2021)

Hopamine as Personalized Medicine for Persons with Parkinson’s Disease
por: Noordegraaf, Marina A., et al.
Publicado: (2023)

Human brain pathology in myotonic dystrophy type 1: A systematic review
por: Weijs, Ralf, et al.
Publicado: (2021)

Pulsatile Proptosis due to Intraorbital Meningocele
por: van Rumund, Anouke, et al.
Publicado: (2017)

Ex vivo visualization of the trigeminal pathways in the human brainstem using 11.7T diffusion MRI combined with microscopy polarized light imaging
por: Henssen, Dylan J. H. A., et al.
Publicado: (2018)

The Role of Microelectrode Recording and Stereotactic Computed Tomography in Verifying Lead Placement During Awake MRI-Guided Subthalamic Nucleus Deep Brain Stimulation for Parkinson’s Disease
por: Vinke, R. Saman, et al.
Publicado: (2022)

Protocol of a single group prospective observational study on the diagnostic value of 3T susceptibility weighted MRI of nigrosome-1 in patients with parkinsonian symptoms: the N3iPD study (nigrosomal iron imaging in Parkinson’s disease)
por: Schwarz, Stefan T, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_okleurcvk58ml3u7jksaf37bln